STUDY ON THE NON-INVASIVE DIAGNOSTIC SYSTEM OF HYPOXIC CELLS IN THE TUMOR BY NEAR-INFRARED SPECTROSCOPY
STUDY ON THE NON-INVASIVE DIAGNOSTIC SYSTEM OF HYPOXIC CELLS IN THE TUMOR BY NEAR-INFRARED SPECTROSCOPY
批准号:
10470198
负责人:
MURAYAMA Chieko
金额:
$6.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000
中文摘要
肿瘤中有低氧细胞作为放射治疗的阻力因素。了解肿瘤中低氧细胞的比率,即肿瘤的氧气状况,对于决定治疗方案是很重要的。因此,在放射治疗前和治疗中,用近红外光谱仪测量患者肿瘤内的氧饱和度,并与治疗效果的关系。作为用非侵入性氧合监测仪(OM-200,岛津)和OMEGAOXYTER(OMEGAMONITOR,BOM-L1)测量肿瘤内氧饱和度的结果,治疗前血氧饱和度有较好的缩小率,分别为70%、60%和以上。肿瘤内血氧饱和度增加10GY照射(照射开始数天后)的肿瘤对辐射高度敏感,似乎可以期待有效的肿瘤减少率。为了进行SPECT非侵袭测量,研制了积聚在低氧细胞中的RADIO活性化合物。为专利应用做了大量的基础实验准备。用抗吡曼硝唑抗体进行免疫组织化学染色,检测其在缺氧细胞中的聚集情况。
英文摘要
THERE ARE HYPOXIC CELLS IN THE TUMOR AS A RESISTANCE FACTOR OF TREATMENT FOR A RADIATION.IT IS IMPORTANT TO KNOW THE RATE OF HYPOXIC CELLS IN THE TUMOR, THAT IS, OXYGEN CONDITION OF THE TUMOR FOR THE DECISION OF THE TREATMENT PRINCIPLE.BY THIS REASON, BEFORE AND DURING A RADIATION TREATMENT, A DEGREE OF OXYGEN SATURATION IN THE TUMOR OF PATIENTS IS MEASURED BY USING NEAR-INFRARED SPECTROSCOPY AND RELATION WITH EFFECT ON TREATMENT IS EXAMINED.AS A RESULT OF MEASURING A DEGREE OF OXYGEN SATURATION IN THE TUMOR WITH NON INVASIVE OXYGENATION MONITOR (OM-200, SHIMADZU) AND OMEGAOXYMETER (OMEGAMONITOR, BOM-L1), IT COULD SHOW A TENDENCY TO GET THE GOOD TUMOR REDUCTION RATE FOR A DEGREE OF OXYGEN SATURATION BEFORE THE TREATMENT WHICH TO BE RESPECTIVELY SUPERIOR IN 70%, 60% AND MORE.THE TUMOR THAT DEGREES OF OXYGEN SATURATION IN THE TUMOR INCREASE BY 10GY IRRADIATION (AFTER AN IRRADIATION START SEVERAL DAYS) SHOWS HIGH SENSITIVITY TOWARD THE RADIATION, AND SEEMS THAT IT CAN EXPECT AN EFFECTIVE TUMOR REDUCTION RATE.RADIO-ACTIVE COMPOUNDS WHICH ACCUMULATE INTO THE HYPOXIC CELLS WERE DEVELOPED FOR THE PURPOSE OF NUN-INVASIVE MEASURING BY SPECT.A LOTS OF FUNDAMENTAL EXPERIMENTS WERE DONE TO PREPARE FOR THE PATENT APPLICATION.FOR ANOTHER METHOD TO RECOGNIZE HYPOXIC CELLS IN THE TUMOR, PIMONIDAZOLE WHICH ALSO ACCUMULATE INTO THE HYPOXIC CELLS WAS DETECTED BY IMMUNOHISTOCHEMISTRY WITH ANTI-PIMONIDAZOLE ANTIBODY.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
CHIEKO MURAYAMA, ET AL: "THE EFFECT OF HYPOXIC CELL RADIOSENSITIZER IN WILD OR MUTANT P53 CELLS"NIPPON ACT RADIOL. 59. S109 (1999)
Chieko MURAYAMA 等人:“缺氧细胞放射增敏剂对野生或突变 P53 细胞的影响”NIPPON ACT RADIOL。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
CHIEKO MURAYAMA, ET AL: "THE EFFECT OF HYPOXIC CELL RADIOSENSITIZER IN WILD OR MUTANT P53 CELLS"J JPN SOC THER RADIOL ONCOL. 11. 322 (1999)
Chieko MURAYAMA 等人:“缺氧细胞放射增敏剂对野生或突变 P53 细胞的影响”J JPN SOC THER RADIOL ONCOL。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
CHIEKO MURAYAMA: "CLINICAL EVALUATION OF HYPOXIC CELL SENSITIZERS."JPN J CANCER CLIN. 46. 301-305 (2000)
Chieko MURAYAMA:“缺氧细胞敏化剂的临床评估。”JPN J CANCER CLIN。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Chieko Murayama, et al.: "Overcoming mutant p53 with hypoxic cell radiosensitizer,PR-350"Radiotherapy and Oncology. 56. S182 (2000)
Chieko Murayama 等人:“用缺氧细胞放射增敏剂 PR-350 克服突变型 p53”放射治疗和肿瘤学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
村山千恵子 他: "ヌードマウス移植ヒト直腸癌に対する低酸素性細胞放射線増感剤PR-350の効果の検討"日本医学放射線学会誌. 59. 897 (1999)
Chieko Murayama 等人:“低氧细胞放射增敏剂 PR-350 对裸鼠移植的人直肠癌的影响的检查”日本医学放射学会杂志 59. 897 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 15 条
Monitoring Mitochondrial Complex-I Activity Using Novel PET Probe 18F-BCPP-EF Allows Early Detection of Radiotherapy Effect in Murine Squamous Cell Carcinoma
-
批准号:26461871
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2014
-
负责人:MURAYAMA Chieko
-
依托单位:
海外基金